"β1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids
The Man␣1,3(Xyl␤1,2)Man␣ structural motif is common to both capsular polysaccharides of Cryptococcus neoformans and to cryptococcal glycosphingolipids. Comparative analysis of glycosphingolipid structural profiles in wild-type and mutant strains showed that the Xyl␤1,2-transferase (Cxt1p) that participates in capsular polysaccharide biosynthesis is also the sole transferase responsible for adding xylose to C. neoformans glycosphingolipids.
The pathogenic basidiomycete Cryptococcus neoformans causes serious disease in immunocompromised patients. A dominant feature of C. neoformans is its polysaccharide capsule, which is required for virulence. Xylose is a key component of both of the major polysaccharides comprising the capsule, glucuronoxylomannan (GXM) and galactoxylomannan (GalXM), and is essential for proper capsule formation and virulence (7, 16) . Xylose is also a feature of C. neoformans glycosylinositol phosphorylceramides (GIPCs) (9) , glycosphingolipids characteristic of fungi (4, 12) . Fungal GIPCs differ fundamentally from mammalian glycosphingolipids in terms of structure, and their biosynthesis is essential for normal growth and life cycle (3, 5) , suggesting they could be exploited for diagnostic (18) and therapeutic strategies (6, 17, 19) . Interestingly, specific structural features are shared between the GIPCs and the capsular polysaccharides of C. neoformans. The GIPC core structure has the overall sequence Man␣3(Xyl␤2) Man␣4Gal␤6Man␣2InsPCer (9) . Like the structures of both GXM and GalXM, this structure includes a branching Xyl␤1,2 residue linked to the reducing mannose of the Man␣1,3Man␣ motif. In a more extensive parallel to GalXM, the xylosylated ␣-mannose of the GIPC core is 1,4-linked to ␤-galactose.
We have recently identified a cryptococcal Xyl␤1,2-transferase (Cxt1p) that acts in synthesizing both capsule polysaccharides (11) . Cells in which CXT1 has been deleted (cxt1⌬:: ⌵〈⌻ [10] ) show a 30% reduction in ␤1,2-Xyl addition to GXM and more than 90% reduction in ␤1,2-xylose addition to GalXM (10) . In light of the structural homologies mentioned above, we tested the hypothesis that this enzyme also adds xylose to GIPCs. To do this, we compared GIPCs from a wild-type strain (JEC21) with those of the cxt1⌬ mutant cells. As a control, we used a strain which bears the deletion of UXS1, the gene encoding UDP-GlcA decarboxylase (1, 16) . This strain (uxs1⌬::ADE2) cannot synthesize the xylose donor UDP-xylose and is therefore globally deficient in the xylose modification of all glycoconjugates.
The C. neoformans JEC21, uxs1⌬ (generously provided to the Doering laboratory by Guilhem Janbon) (16) , and cxt1⌬ strains (10) were grown at 30°C with rotation (200 rpm). All of these strains are closely related serotype D MAT␣ strains: the cxt1⌬ strain was generated directly from JEC21, and the uxs1⌬ strain was made from JEC155, which is derived from a related serotype D MATa strain (JEC20). For lipid preparations, cells were cultured in YPD medium (1% yeast extract, 2% Bacto peptone, 2% glucose) for 3 days, collected by centrifugation (6,000 rpm; 10 min; 4°C), washed once with cold water and twice with cold 20 mM sodium azide, and frozen. The frozen cell pellet (50 to 70 g [wet weight]) was then homogenized with 6 volumes of chloroform-methanol, 1:1 (vol/vol), and solvents were evaporated. Enrichment of glycosphingolipids, recov- Figure 1 shows the HPTLC profiles of GIPCs from the wild-type, the uxs1⌬, and the cxt1⌬ cells. Each of the three strains exhibits a pair of bands that comigrates with a fungal Man␣2InsPCer (MIPC) standard; the differences in the relative distribution of the bands between monohydroxy (upper) N-acyl forms and the dihydroxy (lower) N-acyl forms may reflect strain variation. (Consistent with this idea, the distribution of MIPC bands in the cxt1⌬ strain is similar to that of the bands in JEC21, its immediate parent strain [ is somewhat altered.) Significantly, the wild-type cells also express major low-mobility components (Cn-5 and Cn-6) in a darkly stained band that is completely absent from both the cxt1⌬ and the uxs1⌬ cells. In contrast, the dominant product in the cxt1⌬ strain is a pair of higher-mobility components (Cn-4) whose migration is consistent with that of compounds that are less polar than those of the major wild-type species. The pattern in the uxs1⌬ strain, the control strain completely lacking UDP-xylose, is nearly identical. While this work was in progress, Gutierrez et al. (8) reported that the major GIPC species in the uxs1⌬ cells is a truncated compound, Man␣ 3Man␣4Gal␤6Man␣2InsPCer. The production of the same species in the cxt1⌬ cells (Fig. 1) demonstrates that Cxt1p is responsible for the transfer of all xylose to cryptococcal GIPCs.
We next performed structural studies to confirm the HPTLC comigration and identities of dominant products from the uxs1⌬ and cxt1⌬ strains. We first performed electrospray ion- 1,912, 1,928) . These results correspond to those of the previously characterized Man␣2InsPCer (Cn-1), Man␣3(Xyl␤2)Man␣4Gal␤6Man␣2InsPCer (Cn-5), and Man␣6Man␣3(Xyl␤2)Man␣4Gal␤6Man␣2InsPCer (Cn-6) GIPC sequences (9) . The m/z difference of 16 between molecular adduct pair members is consistent with the differences between the degrees of hydroxylation of the ceramide fatty-N-acyl group (t18:0 4-hydroxy-sphinganine with h24:0 and h 2 24:0 fatty acids, respectively). These results show that the low R f band in the wild-type HPTLC profile (Fig. 1) corresponds to four components, Cn-5 and Cn-6, in an approximately 1:1 ratio, each bearing two types of ceramide. The profile of JEC21, thus, differs somewhat from those of the wild-type strains previously characterized (strain 444, which expressed Cn-5 almost exclusively, and strain KN99, which expressed Cn-6 almost exclusively [8, 9] ).
The uxs1⌬ and cxt1⌬ mutant profiles are shown in Fig. 2A -4) (8) . We detected traces of components with intermediate numbers of Hex residues in the mutant GIPC profiles, but no trace of xylosylated GIPC products were detected in either mutant profile. These results are summarized in Table 1 .
To confirm the lack of xylose in mutant GIPC molecular species, each molecular adduct in both profiles was selected for further fragmentation by the (Fig. 2D) showed that all of the glycosidic cleavages were consistent with those of a linear Hex 4 InsP primary fragment ( Fig. 3 ; Table 2 Our data show that the lack of a single xylosyltransferase, Cxt1p, results in the complete absence of xylose from GIPCs of cryptococcal cells. This loss of xylose yields glycolipids that are indistinguishable from those formed in the uxs1⌬ cells, where no xylose can be added to any glycans. The absence of residual xylose-containing GIPCs in the cxt1⌬ mutant further indicates that no other enzyme performs the function of xylose addition during GIPC synthesis. In agreement with findings described by Gutierrez et al. (8), we observed that the lack of xylose modification of GIPC structures is accompanied by truncation of the terminal mannose residues distal to the branch.
Using in vitro assays, we have found that Cxt1p transfers xylose in ␤1,2 linkage to a Man␣3Man disaccharide (11); our recent in vivo results further show that the cxt1⌬ mutant is partially deficient in the transfer of Xyl␤2 to both GXM and GalXM (10) . Together, these data and the current studies demonstrate that Cxt1p is an unusual multiple-function xylosyltransferase that acts in three fundamental processes of C. neoformans: GXM synthesis, GalXM synthesis, and GIPC synthesis. The critical importance of the addition of xylose to cryptococcal biology and virulence (7, 16) suggests that this fungus-specific protein warrants further investigation, in particular with respect to its role in cryptococcal pathogenesis.
